BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29515034)

  • 1. Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice.
    Chartoumpekis DV; Yagishita Y; Fazzari M; Palliyaguru DL; Rao UN; Zaravinos A; Khoo NK; Schopfer FJ; Weiss KR; Michalopoulos GK; Sipula I; O'Doherty RM; Kensler TW; Wakabayashi N
    JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
    Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
    Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic repression of miR-17 contributed to di(2-ethylhexyl) phthalate-triggered insulin resistance by targeting Keap1-Nrf2/miR-200a axis in skeletal muscle.
    Wei J; Hao Q; Chen C; Li J; Han X; Lei Z; Wang T; Wang Y; You X; Chen X; Li H; Ding Y; Huang W; Hu Y; Lin S; Shen H; Lin Y
    Theranostics; 2020; 10(20):9230-9248. PubMed ID: 32802189
    [No Abstract]   [Full Text] [Related]  

  • 4. Curcumin upregulates the Nrf2 system by repressing inflammatory signaling-mediated Keap1 expression in insulin-resistant conditions.
    Ren L; Zhan P; Wang Q; Wang C; Liu Y; Yu Z; Zhang S
    Biochem Biophys Res Commun; 2019 Jun; 514(3):691-698. PubMed ID: 31078267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forced Hepatic Expression of NRF2 or NQO1 Impedes Hepatocyte Lipid Accumulation in a Lipodystrophy Mouse Model.
    Wakabayashi N; Yagishita Y; Joshi T; Kensler TW
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
    Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processed Meat Protein Promoted Inflammation and Hepatic Lipogenesis by Upregulating Nrf2/Keap1 Signaling Pathway in Glrx-Deficient Mice.
    Ahmad MI; Zou X; Ijaz MU; Hussain M; Liu C; Xu X; Zhou G; Li C
    J Agric Food Chem; 2019 Aug; 67(32):8794-8809. PubMed ID: 31345023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cullin 3 RING E3 ligase inactivation causes NRF2-dependent NADH reductive stress, hepatic lipodystrophy, and systemic insulin resistance.
    Gu L; Du Y; Chen J; Hasan MN; Clayton YD; Matye DJ; Friedman JE; Li T
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2320934121. PubMed ID: 38630726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling.
    Guan L; Zhang L; Gong Z; Hou X; Xu Y; Feng X; Wang H; You H
    Hepatology; 2016 Jun; 63(6):1914-27. PubMed ID: 26857210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad.
    Sparaneo A; Fabrizio FP; Muscarella LA
    Oxid Med Cell Longev; 2016; 2016():7316492. PubMed ID: 27847554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of pterostilbene in attenuating immune mediated devastation of pancreatic beta cells via Nrf2 signaling cascade.
    Sireesh D; Ganesh MR; Dhamodharan U; Sakthivadivel M; Sivasubramanian S; Gunasekaran P; Ramkumar KM
    J Nutr Biochem; 2017 Jun; 44():11-21. PubMed ID: 28343084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice.
    Brachs S; Winkel AF; Polack J; Tang H; Brachs M; Margerie D; Brunner B; Jahn-Hofmann K; Ruetten H; Spranger J; Schmoll D
    PLoS One; 2016; 11(11):e0166110. PubMed ID: 27814396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-canonical NRF2 activation promotes a pro-diabetic shift in hepatic glucose metabolism.
    Liu P; Dodson M; Li H; Schmidlin CJ; Shakya A; Wei Y; Garcia JGN; Chapman E; Kiela PR; Zhang QY; White E; Ding X; Ooi A; Zhang DD
    Mol Metab; 2021 Sep; 51():101243. PubMed ID: 33933676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
    Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
    FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KEAP1/NRF2 axis regulates H
    He J; Zhang X; Lian C; Wu J; Fang Y; Ye X
    Gene; 2019 Apr; 691():8-17. PubMed ID: 30594636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
    Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
    Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.